Drug search by name

Brodalumab Subcutaneous and Crohn's disease

Result of checking the interaction of drug Brodalumab Subcutaneous and disease Crohn's disease for safety when used together.

Check result:

Brodalumab Subcutaneous <> Crohn's disease

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of brodalumab is contraindicated in patients with Crohn's disease as this agent may cause worsening of the disease. It is recommended to discontinue the use of brodalumab if patients develop Crohn's disease while on treatment.

Brodalumab Subcutaneous

Generic Name: brodalumab

Brand Name: Siliq

Synonyms: Brodalumab

What is Brodalumab Subcutaneous?